Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: The MAGIC cell randomised clinical trial

Lancet

Volumn 363, Issue 9411, 2004, Pages 751-756

  Kang, Hyun Jae ^a   Kim, Hyo Soo ^a   Zhang, Shu Ying ^a   Park, Kyung Woo ^a   Cho, Hyun Jai ^a   Koo, Bon Kwon ^a   Kim, Yong Jin ^a   Lee, Dong Soo ^a   Sohn, Dae Won ^a   Han, Kyou Sup ^a   Oh, Byung Hee ^a   Lee, Myoung Mook ^a   Park, Young Bae ^a  

^a Seoul National University Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; DIPYRIDAMOLE; DOBUTAMINE; GLYCERYL TRINITRATE; GRANULOCYTE COLONY STIMULATING FACTOR; HEPARIN; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; NICORANDIL; THALLIUM 201;

ADULT; AGED; ARTICLE; CARDIOVASCULAR INFLAMMATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY STENT; DEATH; DISEASE EXACERBATION; DRUG EFFICACY; DRUG SAFETY; DYSPNEA; EXERCISE; FEMALE; FOLLOW UP; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE CONTRACTION; HEART MUSCLE PERFUSION; HUMAN; INTRACORONARY INFUSION; ISCHEMIA; MALE; PAIN; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; RESTENOSIS; REVASCULARIZATION; RISK ASSESSMENT; THORAX PAIN;

EID: 12144286350     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(04)15689-4     Document Type: Article

References (19)

1. Assmus B., Schächinger V., Teupe C., et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation. 106:2002;3009-3017.
2. Strauer B.E., Brehm M., Zeus T., et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation. 106:2002;1913-1918.
3. Tse H.F., Kwong Y.L., Chan J.K.F., Lo G., Ho C.L., Lau C.P. Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation. Lancet. 361:2003;47-49.
4. Perin E.C., Dohmann H.F.R., Borojevic R., et al. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation. 107:2003;2294-2302.
5. Orlic D., Kajstura J., Chimenti S., et al. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci USA. 98:2001;10344-10349.
6. Anderlini P., Przepiorka D., Champlin R., Korbling M. Biologic and clinical effects of granulocyte colony-stimulating factor in normal individuals. Blood. 88:1996;2819-2825.
7. Cavallaro A.M., Lilleby K., Majolino I., et al. Three to six year follow-up of normal donors who received recombinant human granulocyte colony-stimulating factor. Bone Marrow Transplant. 25:2000;85-89.
8. Bensinger W., Singer J., Appelbaum F., et al. Autologous transplantation with peripheral blood mononuclear cells collected after administration of recombinant granulocyte stimulating factor. Blood. 81:1993;3158-3163.
9. The COBE Spectra Apheresis System Operator's Manual. Lakewood: COBE BCT, 1999.
10. Germano G., Kiat H., Kavanagh P.B., et al. Automatic quantification of ejection fraction from gated myocardial perfusion SPECT. J Nucl Med. 36:1995;2138-2147.
11. Lee D.S., Cheon G.J., Ahn J.Y., Chung J.K., Lee M.C. Reproducibility of assessment of myocardial function using gated 99Tc(m)-MIBI SPECT and quantitative software. Nucl Med Commun. 21:2000;1127-1134.
12. Schiller N.B., Shah P.M., Crawford M., et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography: American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr. 2:1989;358-367.
13. Hill JM, Paul JD, Powell TM, et al. Efficacy and risk of granulocyte colony stimulating factor administration in patients with severe coronary artery disease, Circulation 2003; 108 (suppl IV): 478 (abstr).
14. Ellis SG. Mobilizing stem cells to treat acute myocardial infarction: The first results from RECOVER pilot. Hearing on transcatheter cardiovascular therapeutics 2003, The Molecular Cardiology Symposium 1: Myogenesis, (September 15, 2003).
15. Wexler S.A., Donaldson C., Denning-Kendall P., Rice C., Bradley B., Hows J.M. Adult bone marrow is a rich source of human mesenchymal 'stem' cells but umbilical cord and mobilized adult blood are not. Br J Haematol. 121:2003;368-374.
16. Theilgaard-Monch K., Raaschou-Jensen K., Palm H., et al. Flow cytometric assessment of lymphocyte subsets, lymphoid progenitors, and hematopoietic stem cells in allogeneic stem cell grafts. Bone Marrow Transplant. 28:2001;1073-1082.
17. Fritsch G., Stimpfl M., Kurz M., et al. The composition of CD34 subpopulations differs between bone marrow, blood and cord blood. Bone Marrow Transplant. 17:1996;169-178.
18. Sata M., Saiura A., Kunisato A., et al. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med. 8:2002;403-409.
19. Cho H.J., Kim H.S., Lee M.M., et al. Mobilized endothelial progenitor cells by granulocyte-macrophage colony-stimulating factor accelerate reendothelialization and reduce vascular inflammation after intravascular radiation. Circulation. 108:2003;2918-2925.